F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment

The panel voted unanimously to recommend that the agency approve a treatment that genetically alters a patient’s own cells to fight leukemia.

from NYT > U.S. https://www.nytimes.com/2017/07/12/health/fda-novartis-leukemia-gene-medicine.html?partner=rss&emc=rss
via NY Times

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s